$CELG Recent News Two growth stocks that look ready to

New Post Public Reply Private Reply Replies (0) Message Board

Dec 16, 2013 at 10:40 AM

$CELG Recent News

Two growth stocks that look ready to fly 1:29 p.m. Dec. 12, 2013 - The Trading Deck
Nasdaq makes first close above 4,000 in 13 years: stock market live blog recap 5:03 p.m. Nov. 26, 2013 - blogs.marketwatch.com
What the worst advisers are recommending 1:16 p.m. Nov. 21, 2013 - Mark Hulbert
Top performers’ top November bets 11:01 p.m. Nov. 3, 2013 - Mark Hulbert
Celgene raises earnings outlook as sales climb 7:27 a.m. Oct. 24, 2013 - MarketWatch.com
A bull market as typical as any other 11:23 a.m. Oct. 22, 2013 - The Trading Deck
No shortcut to innovation 7:30 a.m. Oct. 2, 2013 - Mark Hulbert
Market uptrend bends, without cracking 11:55 a.m. Oct. 1, 2013 - Michael Ashbaugh
Market technicals bend, without cracking 11:38 a.m. Oct. 1, 2013 - Michael Ashbaugh
Of keg parties and Big Ben 11:29 a.m. Sept. 19, 2013 - The Trading Deck
Updates, advisories and surprises 4:31 p.m. July 25, 2013 - MarketWatch
Tech ETF QQQ gains on Facebook, other earnings 8:48 a.m. July 25, 2013 - Victor Reklaitis
Celgene profit up 30% as Revlimid sales increase 6:55 a.m. July 25, 2013 - MarketWatch.com
4 things traders should know for the next 24 hours 5:37 p.m. July 24, 2013 - blogs.marketwatch.com
The Next 24: Internet Stocks Jump 3:39 p.m. July 24, 2013 - MarketWatch
Charting a slow-motion rally to record territory 11:06 a.m. July 23, 2013 - Michael Ashbaugh
Charting a slow-motion rally to record territory 10:50 a.m. July 23, 2013 - Michael Ashbaugh
Thursday’s movers: Microsoft rallies on revamp 3:44 p.m. July 11, 2013 - Sue Chang
Celgene's study data may boost cancer drug sales 1:37 p.m. July 11, 2013 - MarketWatch.com
Celgene shares surge on test results from cancer treatment 10:36 a.m. July 11, 2013 - Russ Britt

What To Buy: Celgene Corporation's Buy Recommendation Reiterated 9:00 a.m. Today - TheStreet.com
How big pharma sells A.D.H.D 5:13 p.m. Dec. 15, 2013 - Seeking Alpha
Ziopharm: Finally A Winner In The War On Cancer? 1:22 p.m. Dec. 15, 2013 - Seeking Alpha
2013 Top Stocks Netflix, Micron May Not Do as Well in 2014 10:55 a.m. Dec. 13, 2013 - TheStreet.com
Celgene, Agios Extend Tie-up - Analyst Blog 11:30 a.m. Dec. 12, 2013 - Zacks.com
3 Large Cap Healthcare Stocks That Belong in Your Portfolio 9:23 a.m. Dec. 12, 2013 - Wall St. Cheat Sheet
Follow The Money 5:23 a.m. Dec. 12, 2013 - Seeking Alpha
Spread the Love With CELG Stock Options 3:20 a.m. Dec. 12, 2013 - InvestorPlace.com
Novartis: 2 Novel Cancer Therapies Show Promising Results 2:13 p.m. Dec. 11, 2013 - Seeking Alpha
Celgene, Agios extend cancer collaboration 2:12 p.m. Dec. 11, 2013 - Seeking Alpha
Celgene And The Chronic Disease Fund: The Next Domino To Fall? 12:08 p.m. Dec. 11, 2013 - Seeking Alpha
Will Biotech Outperform Again in 2014? 10:47 a.m. Dec. 11, 2013 - Barrons.com
Biotech Stock Roundup: GILD Scores FDA Approval, Ambit Plunges - Analyst Blog 10:41 a.m. Dec. 11, 2013 - Zacks.com
The Best Biotech CEO of 2013 is... 10:01 a.m. Dec. 11, 2013 - TheStreet.com
The One True Sector Bubble: Profits Here When It Crashes Soon 9:17 a.m. Dec. 11, 2013 - benzinga.com
Credit Suisse Offers Top Biotech Stocks to Buy for 2014 8:10 a.m. Dec. 11, 2013 - 247WallSt.com
Did The Government Shutdown Help The Economy? 6:39 p.m. Dec. 10, 2013 - Seeking Alpha
Celgene Rises on Positive Revlimid Data - Analyst Blog 5:20 p.m. Dec. 10, 2013 - Zacks.com
Jim Cramer's 6 Stocks in 60 Seconds: FDX PVH TWTR BURL CELG PF (Update 1) 5:10 p.m. Dec. 10, 2013 - TheStreet.com
Newly Transformed Nuvilex To Enjoy Strong 2014 11:33 a.m. Dec. 10, 2013 - Seeking Alpha

Agios Advances Cancer Metabolism Collaboration with Celgene 8:16 a.m. Dec. 11, 2013 - BusinessWire
Studies Evaluating REVLIMID(R) (Lenalidomide) in Lymphoma Presented at ASH 7:00 p.m. Dec. 10, 2013 - BusinessWire
Two Studies Highlight Retrospective Analyses of Phase III Study of POMALYST(R)/IMNOVID(R) (Pomalidomide) in Previously Treated Multiple Myeloma Patients Presented at ASH 8:30 a.m. Dec. 10, 2013 - BusinessWire
REVLIMID(R) (lenalidomide)-Treated Patients with Deletion-5q MDS Who Achieve Transfusion-Independence of At Least 26 Weeks and AML-Free Survival Associated with Cytogenetic Response 7:30 p.m. Dec. 9, 2013 - BusinessWire
Stock Price Movements, Completed Acquisitions, and New Clinical Studies - Research Report on UnitedHealth Group, Mylan, St. Jude Medical, and Cigna 8:00 a.m. Dec. 9, 2013 - PR Newswire
First Analysis of Extended Dosing with Celgene Epigenetic Agent CC-486 in Patients with Higher-Risk Myelodysplastic Syndromes Presented at ASH 9:37 p.m. Dec. 7, 2013 - BusinessWire
Biotech Briefing: Advancing Biotechs Forging Ahead With Breaking News Developments: Alliqua, OncoMed Pharmaceuticals, EnteroMedics, Unilife, Amarin 9:05 a.m. Dec. 4, 2013 - PR Newswire
OncoMed and Celgene Announce Strategic Collaboration Advancing Multiple Anti-Cancer Stem Cell Therapeutics to Offer Potential Benefits to Cancer Patients 7:30 a.m. Dec. 3, 2013 - GlobeNewswire
Positive Opinion, Stock Price Movement, and Executive Appointments - Research Report on Celgene, Sirona, Centene, Fresenius Medical Care, and PerkinElmer 8:00 a.m. Nov. 28, 2013 - PR Newswire
Critical Alerts For American Express, Celgene, Altera, JC Penney, and Coach Released By InvestorsObserver 9:31 a.m. Nov. 25, 2013 - PR Newswire
Today's Research: Celgene Corp., Forest Laboratories Inc., Edwards Lifesciences Corp., and Peregrine Pharma Inc. 1:30 p.m. Nov. 22, 2013 - PR Newswire
Celgene Receives Positive CHMP Opinion for ABRAXANE(R) in Combination with Gemcitabine as Treatment for Patients with Metastatic Pancreatic Cancer 7:25 a.m. Nov. 22, 2013 - BusinessWire
FDA Approvals, Stock Price Movements, and Study Results - Research Report on Pfizer, Celgene, Merck, Quest Diagnostics, and Pharmacyclics 8:00 a.m. Nov. 21, 2013 - PR Newswire
Alliqua Announces Transaction with Celgene 7:30 a.m. Nov. 19, 2013 - BusinessWire
Acquisitions, Quarterly Reports, and Stock Price Movements - Research Report on Santarus, Celgene, Pharmacyclics, Quest Diagnostics, and Stryker 8:00 a.m. Nov. 13, 2013 - PR Newswire
Initial Phase III Results of the FIRST(R) Trial (MM-020/IFM 07 01) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (PTS) Ineligible for Stem Cell Transplantation (SCT) Accepted for Plenary Presentation at ASH Annual Meeting 9:02 a.m. Nov. 7, 2013 - BusinessWire
Positive Clinical Data, Upcoming Presentations, and Completed Acquisitions - Research Report on Merck, Perrigo, Celgene, Cigna, and Boston Scientific 8:00 a.m. Nov. 6, 2013 - PR Newswire
Pre-Market Review: Celgene Corp., Forest Laboratories Inc., Peregrine Pharma Inc., and Edwards Lifesciences Corp. 4:03 p.m. Oct. 31, 2013 - PR Newswire
Healthcare Companies Report Quarterly Financial Results - Research Report on Celgene, Natus, Merit Medical, Invacare, and Zalicus 9:00 a.m. Oct. 30, 2013 - PR Newswire
Celgene Corporation to Webcast at Upcoming Investor Conferences and Medical Congress 8:30 a.m. Oct. 30, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jackson Hewitt Aims to Recruit 15,000 Seasonal Staff

Revving Up for Tax Season: Jackson Hewitt's Hiring Push When tax season looms, the hustle can't be understated, and Jackson Hewitt is cranking it up by hunting for 15,000 new recruits to tackle this annual financial circus. Starting October 26, this hiring fest is open season across the nation, pulling out all the stops to bolster its workforce. But what does this mean...

Winter Prep: Home Safety Vital for Older Adults

Cold Weather is All About Precaution It ain't the first day at the fair when you realize winter's sneaking up, and with it, the looming concern of older family members hunkering down indoors. Executive Home Care's calling out, saying it straight: if you've got seniors in your midst, now's the time to batten down the hatches. The winter months can turn into a slippery...

Ars X Machina Lands Spot on 2026 Inc. Power Partner Awards

Charting New Territory in Media Excellence You look at a landscape crowded with media agencies, and Ars X Machina (AXM) is really carving out a niche with its no-nonsense, results-driven approach. Not every day, you see a company making good on lofty promises, but here we are, in 2026, and AXM is locking down that Inc. Power Partner accolade for the second year running....

STEM Grant Boosts Outdoor Learning in Shelbyville

Supporting Future Leaders in STEM Some news is like finding a hidden gem in your backyard. This one comes from the hushed fields of Shelbyville, Indiana, where Girls Inc. of Shelbyville is making waves with a $25,000 grant from the American Water Charitable Foundation. It's no surprise that Indiana American Water is celebrating this landmark move, given that they're...

CATL's Dual-Electric Battery Will Boost Trucking

CATL's Game-Changer in Heavy-Duty Truck Batteries When CATL unveils something new, it's like dropping a sledgehammer on a penny—a big impact that makes you wonder what took so long, and here they are rolling out their dual-electric range extension battery. Tackling two birds with one stone, they're pushing electric heavy-duty trucks into a whole new gear. This isn't...

Arbor Scientia Snags Second Consecutive BASA Win

Picture a small business breaking into the spotlight, grabbing the industry’s attention two years in a row: That’s the story of Arbor Scientia Group (ASG), bagging its second consecutive BASA Award. Celebrated within the Education and Training category, this global medical education and communications agency—not just a regular name in the field—has made measurable...

TrewUp Scores Another Inc. Power Partner Award Win

Breaking Through the Noise in B2B Nobody today would be shocked to hear business owners are practically drowning in options when it comes to B2B service providers. But amid this noisy sea, TrewUp has managed to shout louder than the rest by grabbing a 2026 Inc. Power Partner Awards win—for the second year in a row, no less. It seems like they’ve cracked some sort of...

JELD-WEN Schedules Q3 2026 Earnings Call Amid Global Reach

Looking Ahead: JELD-WEN's Q3 Results Exploration Alright folks, buckle up. JELD-WEN Holding, Inc., the name any DIY'er worth their salt recognizes for doors and windows, has set the stage for unveiling its third quarter 2026 performance. They've earmarked November 3 post-market for us to comb through the numbers, and they're wasting no time by getting on a conference call...

AEP Boosts Dividend Amid $78 Billion Expansion Plan

Dividend Hike Sets the Stage Kicking things off with a neat little surprise, American Electric Power (NASDAQ:AEP) has decided to fatten up that dividend check to 97 cents per share—or a solid 2-cent bump. Now, that might not have you dancing on the trading floor, but it sure shows us that AEP's got intentions worth watching. We're looking at a December 10 payday, so...

PMET’s Shaakichiuwaanaan Drilling Hits 30,000m Milestone

Drilling Deep: PMET's Quest for Mineral Riches You’d be hard-pressed to find another player pushing dirt as fervently as PMET Resources right now. They’ve got their hooks deep into Shaakichiuwaanaan in Quebec—and with over 30,000 meters of drilling chalked up from their elbow grease this year, you better believe it’s shaping up to be a geologist’s dream or a...